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Our ongoing studies investigate the potential role of herpes simplex virus 
type 1 (HSV-1) and Chlamydia pneumoniae (Cpn) in the pathogenesis of 
neurodegenerative disorders, such as Alzheimer’s disease. Since both HSV-1 
and Cpn are ubiquitous and have the ability to persist in a latent state, 
with the potential for reactivation to a productive infection, it is 
reasonable to postulate that infection by either or both pathogens might 
contribute to the gradual accumulation of pathology associated with 
neurodegeneration. This current study examines whether an astrocyte cell 
line can be simultaneously infected by these two pathogens and if co-
infection alters pathogen replication and/or cellular pathology associated 
with infection by either pathogen individually.  
It is known that both HSV-1 and Cpn can utilize heparin sulfate as 
receptors, thus the presence of one pathogen might interfere with 
attachment and internalization of the second pathogen. Furthermore, Cpn 
enters a state of persistence in response to changes in the host cell 
environment and we speculate that productive HSV-1 infection might set up 
an intracellular environment that induces persistence in Cpn. It is possible 
that both Cpn and HSV-1 might cycle through periods of productive 
infection and latency, thereby contributing to progressive neuropathology. 
To assess whether the presence of HSV-1 alters Cpn gene expression, the 
relative levels of 6 different Cpn genes involved in different stages of the 
replication cycle were examined in RNA from cells infected with Cpn alone 
or dually infected with Cpn and HSV-1. The genes examined are listed in 
Table 1; L-29, TUF, and ABCX have been designated as potential chlamydial 
housekeeping genes whose expression remains relatively constant 
throughout the replication cycle (1). In this study, we use L-29 as an 
endogenous control to normalize quantity of Cpn in the different samples 
within an experiment. Immunofluorescence and determination of viral 
titers provide additional methodology to further evaluate Cpn or HSV-1 
infection of astrocytes. 
Abstract Methods 
Cell Culture:  An astrocyte cell line (STTG-1; ATCC) was cultured in RPMI-1640 (RPMI) with 10% heat-inactivated FBS. Cells were maintained at 37°C in 
5% CO2. Infections were performed in 12 well plates seeded with 2 x 10
5 cells per well; astrocytes were infected when monolayers were 50-70% 
confluent (5-8 x 106 cells per well). 
Infection:  Astrocytes were mock infected with RPMI alone, or inoculated with Chlamydia pneumoniae AR-39 (Cpn; ATCC) and/or Herpes simplex virus 
1 (HSV-1; ATTC) for 24 or 48 hours. The HSV inoculum was an approximate MOI of 0.2, while the Cpn inoculum was 0.7. Cpn and HSV-1 were allowed to 
attach to astrocyte monolayers in 0.3 ml RPMI for 1 hour, after which time the volume was maintained at 1 ml for the duration of the infection. Co-
infections included the simultaneous inoculation of HSV-1 and Cpn (HSV/Cpn 48/48) or addition of the second pathogen at 24 hours post infection 
(hpi), which allowed one pathogen to establish infection before addition of the second one (HSV/Cpn 48/24 and HSV/Cpn 24/48). Cells from co-
infected monolayers were harvested at 48 hpi. A qualitative evaluation of infection by Cpn and HSV-1 was assessed by immunofluorescent labeling for 
the two pathogens using antibodies specific for Cpn (Fitzgerald; 61C75-A) and HSV-1 (Abcam; ab9533). In addition, HSV-1 present in culture supernates 
of single and dual infections was titered by plaque assay. 
Analysis of gene expression: RNA or DNA was isolated from infected and uninfected cell monolayers using Qiagen’s RNeasy Mini Kit or DNA Blood & 
Tissue Kit, respectively, following the manufacturer’s directions. RNA was reverse transcribed (Retroscript kit; Ambion), and the expression of Cpn 
genes and cellular actin and GAPDH was quantified from RNA by RT2-PCR using TaqMan gene expression assays (Invitrogen/Life Technologies). The Cpn 
gene L-29 was used as an endogenous control to assess relative expression of Cpn genes; this gene was designated as a potential housekeeping gene for 
Cpn in a prior investigation (1). HSV-1 or Cpn sequences in DNA samples were quantified by RT-PCR using primers specific for HSV-1 or Cpn 
(PrimerDesign) following the manufacturer’s recommended protocol.  
Introduction 
Results 
Results – summary 
• Single or dual infections contained similar levels of HSV-1 at 
48hrs post infection, however, at 24 hours post infection some 
inhibition of HSV-1 was observed in monolayers previously 
infected with Cpn 
• HSV-1-induced syncytia formation was observed at 48hrs post 
infection in the presence or absence of Cpn 
• HSV-1 inhibited host cell expression of GAPDH and Actin; extent 
of inhibition correlates with amount of HSV-1 present in the 
infected monolayers  
• Immunofluorescent labeling revealed astrocytes can be 
simultaneously infected with both HSV-1 and Cpn 
• Co-infected monolayers had similar levels of Cpn as the 48hr 
single infections 
• Cpn genes showed similar levels of expression when normalized 
using a Cpn housekeeping gene 
Conclusions 
• The presence of Cpn may inhibit initial viral attachment 
and/or entry 
• Cpn does not prevent HSV-1 induced cytopathology 
• HSV-1 can alter gene expression in astrocytes 
• The presence of one pathogen does not prevent intracellular 
replication of the other one 
• Differential Cpn gene expression is not observed in single vs 
dual infections with the genes examined in this study 
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Figure 1. Quantification of Cpn from infected astrocytes in the 
presence or absence of HSV-1. Astrocyte monolayers were infected 
with Cpn alone or co-infected with Cpn and HSV-1. Cpn DNA was 
quantified by RT-PCR using a Cpn 16S rRNA-specific primer; copy 
number was calculated from a standard curve derived from 
amplification of a known concentration of primer-specific sequences 
and expressed relative to that of the 48 hour single Cpn infection. 
Results represent the mean and standard deviation from 4 separate 
experiments. 
 
Figure 4. Immunofluorescent labeling and phase contrast microscopy of astrocytes infected with 
HSV-1 and/or Cpn.  In the two left columns, infected astrocytes were labeled by immunofluoresence 
for HSV-1 (red) and Cpn (green); cell nuclei are in blue. Phase contrast microscopy (third column) 
revealed HSV-1-induced syncytia formation and cell rounding at 48 hpi in the presence or absence of 
Cpn; minimal HSV-1-induced cellular damage was noted at 24 hpi (data not shown).  
Table 1. Identification of select chlamydial genes analyzed in this study. Background and Significance: Chlamydia pneumoniae (Cpn) and Herpes 
simplex virus type 1 (HSV-1) have been studied as pathogens contributing to 
neurodegenerative diseases. Since Cpn and HSV-1 are both ubiquitous, 
many individuals presumably are exposed to both pathogens during their 
life time. We speculate that the two pathogens act synergistically in 
promoting neuropathology. 
Objectives: Determine whether Cpn and HSV-1 can co-infect cells and 
whether HSV-1 induces persistence of Cpn, thereby favoring chronic 
infection by Cpn.  
Methods: The ability of Cpn and HSV-1 to co-infect an astrocyte cell line 
was analyzed by immunofluorescent (IF) labeling of infected cells. The 
relative levels of Cpn or HSV in different samples was quantified by RT-
PCR; expression of various Cpn genes associated with stages of Cpn 
development was quantified by RT2-PCR. DNA or RNA was derived from cells 
infected with Cpn alone, HSV alone, or infected with Cpn and HSV-1. 
Results: IF revealed that cells could be infected with both Cpn and HSV-1. 
When infection with HSV-1 is established prior to addition of Cpn, cells 
demonstrated punctate labeling for Cpn but the frequency of larger 
aggregates of labeling, consistent with chlamydial inclusions, was 
diminished. Data reveal that replication of HSV-1 is lessened but not 
prevented by Cpn, while Cpn replication does not appear to be inhibited by 
HSV-1. 
Conclusions: Inhibition of HSV-1 by Cpn may reflect competition for the 
same cellular receptor. Whereas disruption of host cell transcription by 
HSV-1 may modify normal Cpn development, Cpn is able to replicate in the 
presence of HSV-1.  
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Figure 5. Quantification of HSV-1 from infected astrocytes in the presence or 
absence of Cpn. Astrocyte monolayers were infected with HSV-1 alone or co-infected 
with HSV-1 and Cpn. Viral titers in culture supernates were measured by plaque assay 
and expressed as the Log10 (Plaque Forming Units [PFU]/ml). Results represent the 
mean and standard deviation from 3 separate experiments. HSV DNA was quantified by 
RT-PCR using an HSV-1-specific primer; copy number was calculated from a standard 
curve derived from amplification of a known concentration of primer-specific 
sequences and expressed relative to that of the 48 hour single HSV-1 infection. Results 
represent the mean + SD from 4 separate experiments. 
Figure 2. Amplification of host genes. RNA  derived from single or dually 
infected astrocytes was reverse transcribed and equal amounts of cDNA were 
amplified with primers specific for GAPDH and actin. Levels of actin and GAPDH 
is inversely related to cycle thresholds; expression of these host genes is shown 
relative to that of uninfected samples. The longer the bar in the above plot, the 
greater the copy number of host gene sequences present in RNA. Results 
represent the mean and standard deviation from 2 separate experiments; actin 
data was pooled following amplification using 2 different actin-specific primers. 
Figure 3. Expression of Cpn genes from 
infected astrocytes in the presence or 
absence of HSV-1. Astrocyte monolayers 
were infected with Cpn alone or co-infected 
with Cpn and HSV-1. Relative expression of 
Cpn genes was obtained following RT2-PCR 
amplification of RNA from infected 
monolayers. To assess differential expression 
of Cpn genes in infected astrocytes, L-29 was 
used as an endogenous Cpn control. 
Gene Gene description/function Locus Comment 
16S 16S ribosomal RNA   Standard Curve quantification  
lcrH_1 Low calcium response protein H CPn0811 Marks transition from RB to EB 
hctA 
Histone-like developmental 
protein 
CPn0886 Marks transition from RB to EB 
rpmC 50S ribosomal protein L29 CPn0639 housekeeping gene candidate 
tuf Elongation factor Tu CPn0074 housekeeping gene candidate 
euo Chlamydial repressor protein CPj0561 Early chlamydial gene 
abcX ABC transporter ATPase CPn0691 housekeeping gene candidate 
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